Home » Topics » BioWorld Science

BioWorld Science
RSS

Discovery of novel BRAF dimer inhibitors with promising efficacy

Sep. 22, 2021

New osteoarthritis risk variants and drug targets identified in large GWAS meta-analysis

Sep. 22, 2021

STING agonists show preclinical promise for glioblastoma and pancreatic cancer therapy

Sep. 22, 2021

IL2RA is a prognostic immune marker in epithelial ovarian cancer

Sep. 22, 2021

Identification of genomic correlates of clinical outcomes in metastatic uveal melanoma

Sep. 22, 2021

DIO2 as a new promising prognostic biomarker for patients with early-stage NSCLC

Sep. 22, 2021

New necroptosis inhibitors synthesized at Anaxis Pharma

Sep. 22, 2021

Fochon Pharmaceuticals describes CDK2/CDK4/CDK6 inhibitors

Sep. 22, 2021

Sichuan Kelun-Biotech Biopharmaceutical presents new PPAR receptor agonists

Sep. 22, 2021

Dual SYK/VEGFR2 inhibitors discovered at Ocumension Therapeutics

Sep. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.